SEGMENT INFORMATION

6 Months Ended

Oct. 01, 2011

SEGMENT INFORMATION

11. SEGMENT INFORMATION

Segment Definition Criteria

We manage our business on the basis of one operating segment: the design, manufacture, and marketing of blood management solutions. Our chief operating decision-maker uses consolidated results to make operating and strategic decisions. Manufacturing processes, as well as the regulatory environment in which we operate, are largely the same for all product lines.

Enterprise Wide Disclosures about Product and Services

We have four global product families: plasma, blood center, hospital, and software solutions.

Our products include equipment devices and the related disposables used with these devices. Disposables include the plasma, blood center, and hospital product families. Plasma consists of the disposables used to perform apheresis for the separation of whole blood components and subsequent collection of plasma to be used as a raw material for biologically derived pharmaceuticals (also known as source plasma). Blood center consists of disposables which separate whole blood for the subsequent collection of platelets, plasma, red cells, or a combination of these components for transfusion to patients. Hospital consists of surgical disposables (principally the Cell Saver^® and Cell Saver Elite ^® autologous blood recovery systems targeted to procedures that involve rapid, high volume blood loss such as cardiovascular surgeries and the cardioPAT^® cardiovascular perioperative autotransfusion system designed to remain with the patient following surgery to recover blood and the patient’s red cells to prepare them for reinfusion), the OrthoPAT^® orthopedic perioperative autotransfusion system designed to operate both during and after surgery to recover and wash the patient’s red cells to prepare them for reinfusion, and diagnostics products (principally the TEG^® Thrombelastograph^® hemostasis analyzer used to help assess a surgical patient’s hemostasis (blood clotting ability) during and after surgery).

Disposables (single-use sterile kits used in our devices for collection or salvage of blood products) are marketed in our plasma, blood center, and hospital product businesses. Plasma disposables are used with our PCS^®2 devices to perform apheresis for the collection of plasma to be used as a raw material for biologically derived pharmaceuticals (also known as source plasma). Blood center disposables are used with our MCS+ device to collect one or more blood components (principally platelets but also red cells and plasma) for transfusion to patients. The Hospital business consists of disposables used with our Cell Saver^® and cardioPAT^® devices to recover red cells from blood lost in a surgical procedure so that these may be made available for reinfusion to the patient (“autotransfusion”). OrthoPAT^® disposables are used for autotransfusion during and immediately following orthopedic surgeries. Diagnostics products principally reflect sales of diagnostic reagents and the TEG^® Thrombelastograph^® hemostasis analyzer which profiles a patient’s blood clotting characteristics.

Software solutions include information technology platforms that assist blood centers, plasma centers, and hospitals to more effectively manage regulatory compliance and operational efficiency.

Revenues from External Customers:

	Three Months Ended
	October 1, 2011		October 2, 2010
	(in thousands)
Disposable revenues
Plasma disposables	$	64,408	$	56,514
Blood center disposables
Platelet		42,195		39,746
Red cell		11,645		11,294
		53,840		51,040
Hospital disposables
Surgical		16,206		16,011
OrthoPAT		7,295		8,281
Diagnostics		5,659		4,647
		29,160		28,939
Disposables revenue		147,408		136,493
Software solutions		17,199		16,125
Equipment & other		14,838		14,215
Net revenues	$	179,445	$	166,833

	Six Months Ended
	October 1, 2011		October 2, 2010
	(in thousands)
Disposable revenues
Plasma disposables	$	127,168	$	112,431
Blood center disposables
Platelet		79,504		76,063
Red cell		23,514		22,608
		103,018		98,671
Hospital disposables
Surgical		31,948		32,362
OrthoPAT		15,049		17,238
Diagnostics		11,273		9,355
		58,270		58,955
Disposables revenue		288,456		270,057
Software solutions		35,359		32,585
Equipment & other		26,199		27,230
Net revenues	$	350,014	$	329,872